↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$884KSold on the market
1Companies
Oct 13, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 202616:05 | Oct 12, 2026 | FENCFENNEC PHARMACEUTICALS INC. | CHIEF FINANCIAL OFFICER | A · Grant | $5.53 | +3,846 | 246,855 | +2% | $21K | ||
| Oct 1, 202616:05 | Sep 30, 2026 | FENCFENNEC PHARMACEUTICALS INC. | CHIEF FINANCIAL OFFICER | A · Grant | — | +1,703 | 243,009 | +1% | — | ||
| Aug 31, 202620:09 | Aug 31, 2026 | FENCFENNEC PHARMACEUTICALS INC. | CHIEF FINANCIAL OFFICER | A · Grant | — | +1,703 | 241,306 | +1% | — | ||
| Aug 28, 202617:42 | Aug 27, 2026 | FENCFENNEC PHARMACEUTICALS INC. | CHIEF FINANCIAL OFFICER | S · Sell10b5-1 | $11.78 | −75,000 | 217,675 | -26% | −$884K | ||
| Aug 28, 202617:42 | Aug 28, 2026 | FENCFENNEC PHARMACEUTICALS INC. | CHIEF FINANCIAL OFFICER | M · Exercise10b5-1 | $5.10 | +21,928 | 239,603 | +10% | $112K | ||
| Aug 3, 202616:05 | Jul 31, 2026 | FENCFENNEC PHARMACEUTICALS INC. | CHIEF FINANCIAL OFFICER | A · Grant | — | +1,703 | 292,675 | +1% | — |